The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex

Biological Psychiatry

Volumn 77, Issue 11, 2015, Pages 940-950

  Spencer, Robert C ^a   Devilbiss, David M ^a   Berridge, Craig W ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ADHD; Cognition; Dopamine; Norepinephrine; Prefrontal cortex; Stimulants

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; DOPAMINE 1 RECEPTOR; NORADRENALIN; PSYCHOSTIMULANT AGENT; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; COGNITION; CORPUS STRIATUM; DOSE RESPONSE; HUMAN; NEUROBIOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; WORKING MEMORY; ANIMAL; DRUG EFFECTS;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; HUMANS; PREFRONTAL CORTEX;

EID: 84929277437     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.09.013     Document Type: Review

References (108)

1. D.S. Segal Behavioral and neurochemical correlates of repeated d-amphetamine administration Adv Biochem Psychopharmacol 13 1975 247 262
2. G.V. Rebec, and T.R. Bashore Critical issues in assessing the behavioral effects of amphetamine Neurosci Biobehav Rev 8 1984 153 159
3. J. McGaughy, and M. Sarter Behavioral vigilance in rats: Task validation and effects of age, amphetamine, and benzodiazepine receptor ligands Psychopharmacology (Berl) 117 1995 340 357
4. C.W. Berridge, and T.A. Stalnaker Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex Synapse 46 2002 140 149
5. A.F. Arnsten, and A.G. Dudley Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder Behav Brain Funct 1 2005 2
6. D.M. Devilbiss, and C.W. Berridge Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness Biol Psychiatry 64 2008 626 635
7. C. Bradley The behavior of children receiving benzadrine Am J Psychiatry 94 1937 577 585
8. L.L. Greenhill Clinical effects of stimulant medication in ADHD M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 Oxford University Press New York 31 71
9. L. Hechtman, H. Abikoff, R.G. Klein, G. Weiss, C. Respitz, and J. Kouri Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment J Am Acad Child Adolesc Psychiatry 43 2004 812 819
10. R.M. Scheffler, T.T. Brown, B.D. Fulton, S.P. Hinshaw, P. Levine, and S. Stone Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school Pediatrics 123 2009 1273 1279
11. J.L. Rapoport, M.S. Buchsbaum, H. Weingartner, T.P. Zahn, C. Ludlow, and E.J. Mikkelsen Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men Arch Gen Psychiatry 37 1980 933 943
12. C.J. Vaidya, G. Austin, G. Kirkorian, H.W. Ridlehuber, J.E. Desmond, G.H. Glover, and J.D. Gabrieli Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study Proc Natl Acad Sci U S A 95 1998 14494 14499
13. M.A. Mehta, A.M. Owen, B.J. Sahakian, N. Mavaddat, J.D. Pickard, and T.W. Robbins Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain J Neurosci 20 2000 RC65
14. J.L. Rapoport, and G. Inoff-Germain Responses to methylphenidate in attention-deficit/hyperactivity disorder and normal children: Update 2002 J Atten Disord 6 2002 S57 S60
15. R. Elliott, B.J. Sahakian, K. Matthews, A. Bannerjea, J. Rimmer, and T.W. Robbins Effects of methylphenidate on spatial working memory and planning in healthy young adults Psychopharmacology (Berl) 131 1997 196 206
16. J. Setlik, G.R. Bond, and M. Ho Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications Pediatrics 124 2009 875 880
17. S.E. McCabe, J.R. Knight, C.J. Teter, and H. Wechsler Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey Addiction 100 2005 96 106
18. B. Maher Poll results: Look who's doping Nature 452 2008 674 675
19. R.A. Barkley Attention-deficit/hyperactivity disorder, self-regulation, and time: Toward a more comprehensive theory J Dev Behav Pediatr 18 1997 271 279
20. F.X. Castellanos, and R. Tannock Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes Nat Rev Neurosci 3 2002 617 628
21. B.J. Casey, J.N. Epstein, J. Buhle, C. Liston, M.C. Davidson, and S.T. Tonev Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD Am J Psychiatry 164 2007 1729 1736
22. G. Bush, E.M. Valera, and L.J. Seidman Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions Biol Psychiatry 57 2005 1273 1284
23. J. Swanson, and N. Volkow Pharmacokinetic and pharmacodynamic properties of methylphenidate in humans M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 Oxford University Press New York
24. C.W. Berridge, D.M. Devilbiss, M.E. Andrzejewski, A.F. Arnsten, A.E. Kelley, and B. Schmeichel Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function Biol Psychiatry 60 2006 1111 1120
25. C.W. Berridge, and D.M. Devilbiss Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder Biol Psychiatry 69 2011 e101 e111
26. A.F. Arnsten Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: An important role for prefrontal cortex dysfunction CNS Drugs 23 suppl 1 2009 33 41
27. R. Kuczenski, and D.S. Segal Regional norepinephrine response to amphetamine using dialysis: Comparison with caudate dopamine Synapse 11 1992 164 169
28. R. Kuczenski, D.S. Segal, A.K. Cho, and W. Melega Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine J Neurosci 15 1995 1308 1317
29. R. Kuczenski, and D.S. Segal Neurochemistry of amphetamine A.K. Cho, D.S. Segal, Amphetamine and Its Analogues: Psychopharmacology, Toxicology and Abuse 1994 Academic Press San Diego 81 113
30. S.M. Florin, R. Kuczenski, and D.S. Segal Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment Brain Res 654 1994 53 62
31. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine J Neurochem 68 1997 2032 2037
32. R. Kuczenski, and D.S. Segal Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: Relative roles of dopamine and norepinephrine J Pharmacol Exp Ther 296 2001 876 883
33. R. Kuczenski, and D.S. Segal Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine J Neurosci 22 2002 7264 7271
34. N.J. Gamo, M. Wang, and A.F. Arnsten Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors J Am Acad Child Adolesc Psychiatry 49 2010 1011 1023
35. A.F. Arnsten, and S.R. Pliszka Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders Pharmacol Biochem Behav 99 2011 211 216
36. J.M. Delfs, L. Schreiber, and A.E. Kelley Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat J Neurosci 10 1990 303 310
37. C.W. Berridge Neural substrates of psychostimulant-induced arousal Neuropsychopharmacology 31 2006 2332 2340
38. P.H. Kelly, P.W. Seviour, and S.D. Iversen Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum Brain Res 94 1975 507 522
39. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychol Rev 94 1987 469 492
40. C. Drouin, M. Page, and B. Waterhouse Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats J Neurophysiol 96 2006 622 632
41. J. Biederman Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: Findings from a longitudinal follow-up of youths with and without ADHD J Clin Psychiatry 64 suppl 11 2003 3 8
42. T.E. Wilens, S.V. Faraone, J. Biederman, and S. Gunawardene Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature Pediatrics 111 2003 179 185
43. B.E. Schmeichel, and C.W. Berridge Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants Neuropsychopharmacology 38 2013 1078 1084
44. B. Meyers, and M.F. Kritzer In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex Neuroscience 159 2009 271 282
45. S.R. Sesack, V.A. Hawrylak, C. Matus, M.A. Guido, and A.I. Levey Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter J Neurosci 18 1998 2697 2708
46. B. Giros, Y.M. Wang, S. Suter, S.B. McLeskey, C. Pifl, and M.G. Caron Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters J Biol Chem 269 1994 15985 15988
47. H. Gu, S.C. Wall, and G. Rudnick Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence J Biol Chem 269 1994 7124 7130
48. J.A. Moron, A. Brockington, R.A. Wise, B.A. Rocha, and B.T. Hope Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines J Neurosci 22 2002 389 395
49. F.P. Bymaster, J.S. Katner, D.L. Nelson, S.K. Hemrick-Luecke, P.G. Threlkeld, and J.H. Heiligenstein Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 27 2002 699 711
50. E. Carboni, G.L. Tanda, R. Frau, and C.G. Di Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals J Neurochem 55 1990 1067 1070
51. E. Carboni, A. Silvagni, C. Vacca, and C.G. Di Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex J Neurochem 96 2006 473 481
52. W.A. Cass, and G.A. Gerhardt In vivo assessment of dopamine uptake in rat medial prefrontal cortex: Comparison with dorsal striatum and nucleus accumbens J Neurochem 65 1995 201 207
53. B. Schmeichel, F. Zemlan, and C.W. Berridge A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: Potential relevant to attention deficit hyperactivity disorder Neuropharmacology 64 2012 321 328
54. R.P. Kesner Subregional analysis of mnemonic functions of the prefrontal cortex in the rat Psychobiology 28 2000 219 228
55. M.A. Mehta, I.M. Goodyer, and B.J. Sahakian Methylphenidate improves working memory and set-shifting in AD/HD: Relationships to baseline memory capacity J Child Psychol Psychiatry 45 2004 293 305
56. J.W. Dalley, R.N. Cardinal, and T.W. Robbins Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates Neurosci Biobehav Rev 28 2004 771 784
57. R.P. Vertes Differential projections of the infralimbic and prelimbic cortex in the rat Synapse 51 2004 32 58
58. R.C. Spencer, R.M. Klein, and C.W. Berridge Psychostimulants act within the prefrontal cortex to improve cognitive function Biol Psychiatry 72 2012 221 227
59. A. Armario Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome Trends Pharmacol Sci 31 2010 318 325
60. A. Barsegyan, S.M. Mackenzie, B.D. Kurose, J.L. McGaugh, and B. Roozendaal Glucocorticoids in the prefrontal cortex enhance memory consolidation and impair working memory by a common neural mechanism Proc Natl Acad Sci U S A 107 2010 16655 16660
61. B.W. Balleine, M.R. Delgado, and O. Hikosaka The role of the dorsal striatum in reward and decision-making J Neurosci 27 2007 8161 8165
62. B.W. Balleine, and J.P. O'Doherty Human and rodent homologies in action control: Corticostriatal determinants of goal-directed and habitual action Neuropsychopharmacology 35 2010 48 69
63. P.L. Clatworthy, S.J. Lewis, L. Brichard, Y.T. Hong, D. Izquierdo, and L. Clark Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory J Neurosci 29 2009 4690 4696
64. N.D. Volkow, G.J. Wang, J.S. Fowler, J. Logan, D. Franceschi, and L. Maynard Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications Synapse 43 2002 181 187
65. N.D. Volkow, G.J. Wang, D. Tomasi, S.H. Kollins, T.L. Wigal, and J.H. Newcorn Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder J Neurosci 32 2012 841 849
66. P.L. Gabbott, T.A. Warner, P.R. Jays, P. Salway, and S.J. Busby Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers J Comp Neurol 492 2005 145 177
67. S.B. Floresco, D.N. Braaksma, and A.G. Phillips Thalamic-cortical-striatal circuitry subserves working memory during delayed responding on a radial arm maze J Neurosci 19 1999 11061 11071
68. A. Smith, A. Cubillo, N. Barrett, V. Giampietro, A. Simmons, M. Brammer, and K. Rubia Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination Biol Psychiatry 74 2013 615 622
69. K. Rubia, R. Halari, A. Cubillo, A.M. Mohammad, M. Brammer, and E. Taylor Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task Neuropharmacology 57 2009 640 652
70. K. Rubia, R. Halari, A. Cubillo, A.B. Smith, A.M. Mohammad, M. Brammer, and E. Taylor Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naive boys with attention-deficit hyperactivity disorder Neuropsychopharmacology 36 2011 1575 1586
71. A.F. Marquand, O.G. O'Daly, S. De Simoni, D.C. Alsop, R.P. Maguire, and S.C. Williams Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: A multi-class pattern recognition approach Neuroimage 60 2012 1015 1024
72. A.F. Marquand, S. De Simoni, O.G. O'Daly, S.C. Williams, J. Mourao-Miranda, and M.A. Mehta Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers Neuropsychopharmacology 36 2011 1237 1247
73. A.M. Pauls, O.G. O'Daly, K. Rubia, W.J. Riedel, S.C. Williams, and M.A. Mehta Methylphenidate effects on prefrontal functioning during attentional-capture and response inhibition Biol Psychiatry 72 2012 142 149
74. A. Cubillo, A.B. Smith, N. Barrett, V. Giampietro, M. Brammer, A. Simmons, and K. Rubia Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory Psychol Med 44 2014 633 646
75. M.A. Mehta, B.J. Sahakian, and T.W. Robbins Comparative psycholpharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals M.V. Solanto, A.F.T. Arnsten, F.X. Castellanos, Stimulant Drugs and ADHD: Basic and Clinical Neuroscience 2001 Oxford University Press New York 303 331
76. L. Clark, A.D. Blackwell, A.R. Aron, D.C. Turner, J. Dowson, T.W. Robbins, and B.J. Sahakian Association between response inhibition and working memory in adult ADHD: A link to right frontal cortex pathology? Biol Psychiatry 61 2007 1395 1401
77. T. Lundqvist Imaging cognitive deficits in drug abuse 2009 Springer-Verlag Berlin
78. S. Vijayraghavan, M. Wang, S.G. Birnbaum, G.V. Williams, and A.F. Arnsten Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory Nat Neurosci 10 2007 376 384
79. A.F. Arnsten Through the looking glass: Differential noradenergic modulation of prefrontal cortical function Neural Plast 7 2000 133 146
80. R.D. Hunt, R.B. Minderaa, and D.J. Cohen Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial J Am Acad Child Psychiatry 24 1985 617 629
81. L. Scahill, P.B. Chappell, Y.S. Kim, R.T. Schultz, L. Katsovich, and E. Shepherd A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder Am J Psychiatry 158 2001 1067 1074
82. J. Biederman, R.D. Melmed, A. Patel, K. McBurnett, J. Konow, and A. Lyne A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder Pediatrics 121 2008 e73 e84
83. J.S. Franowicz, and A.F. Arnsten The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys Psychopharmacology (Berl) 136 1998 8 14
84. C.W. Berridge, A.F. Arnsten, and S.L. Foote Noradrenergic modulation of cognitive function: Clinical implications of anatomical, electrophysiological and behavioural studies in animal models [editorial] Psychol Med 23 1993 557 564
85. H. Tanila, P. Rama, and S. Carlson The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats Brain Res Bull 40 1996 117 119
86. Spencer RC, Berridge CW (2013): Receptor and frontostriatal circuit mechanisms underlying the cognition-enhancing actions of psychostimulants. Soc Neurosci Abst 288.16:KKK14
87. Y. Wang, J. Liu, Z.H. Gui, U. Ali, L.L. Fan, and C. Hou alpha2-Adrenoceptor regulates the spontaneous and the GABA/glutamate modulated firing activity of the rat medial prefrontal cortex pyramidal neurons Neuroscience 182 2011 193 202
88. H. Salgado, F. Garcia-Oscos, A. Patel, L. Martinolich, J.A. Nichols, and L. Dinh Layer-specific noradrenergic modulation of inhibition in cortical layer II/III Cereb Cortex 21 2011 212 221
89. J. Cheng, Z. Xiong, L.J. Duffney, J. Wei, A. Liu, and S. Liu Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors [published online ahead of print April 12] Biol Psychiatry. 2014
90. J.K. Seamans, N. Gorelova, D. Durstewitz, and C.R. Yang Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons J Neurosci 21 2001 3628 3638
91. J.K. Seamans, D. Durstewitz, B.R. Christie, C.F. Stevens, and T.J. Sejnowski Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons Proc Natl Acad Sci U S A 98 2001 301 306
92. A.F. Arnsten Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": A rational bridge between genetics and the symptoms of mental illness Cereb Cortex 17 suppl 1 2007 i6 i15
93. R.L. Sprague, and E.K. Sleator Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior Science 198 1977 1274 1276
94. M.V. Solanto Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration Behav Brain Res 94 1998 127 152
95. M.D. Rapport, and K.L. Kelly Psychostimulant effects on learning and cognitive function: Findings and implications for children with attention deficit hyperactivity disorder Clin Psychol Rev 11 1991 61 92
96. R. Tannock, R. Schachar, and G. Logan Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children J Abnorm Child Psychol 23 1995 235 266
97. S. Granon, F. Passetti, K.L. Thomas, J.W. Dalley, B.J. Everitt, and T.W. Robbins Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex J Neurosci 20 2000 1208 1215
98. C. Berridge, J.S. Shumsky, M.E. Andrzejewski, J. McGaughy, R.C. Spencer, D. Devilbiss, and B.D. Waterhouse Differential sensitivity to psychostimulants across prefrontal cognitive tasks: Differential involvement of noradrenergic α1-vs. α2-receptors Biol Psychiatry 71 2012 467 473
99. Spencer RC, Waterhouse BD, Berridge CW (in press): Neurocircuitry and receptor mechanisms underlying the differential sensitivity of prefrontal cognitive processes to psychostimulants. Soc Neurosci Abst.
100. M.D. Lapiz, and D.A. Morilak Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability Neuroscience 137 2006 1039 1049
101. G. Aston-Jones, J. Rajkowski, and J. Cohen Locus coeruleus and regulation of behavioral flexibility and attention Prog Brain Res 126 2000 165 182
102. J.M. Birrell, and V.J. Brown Medial frontal cortex mediates perceptual attentional set shifting in the rat J Neurosci 20 2000 4320 4324
103. A.M. Owen, A.C. Roberts, C.E. Polkey, B.J. Sahakian, and T.W. Robbins Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man Neuropsychologia 29 1991 993 1006
104. A.F. Arnsten, and B.M. Li Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions Biol Psychiatry 57 2005 1377 1384
105. A.F. Arnsten The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder Expert Rev Neurother 10 2010 1595 1605
106. D.R. Doerge, C.M. Fogle, M.G. Paule, M. McCullagh, and S. Bajic Analysis of methylphenidate and its metabolite ritalinic acid in monkey plasma by liquid chromatography/electrospray ionization mass spectrometry Rapid Commun Mass Spectrom 14 2000 619 623
107. R. Navarra, R. Graf, Y. Huang, S. Logue, T. Comery, Z. Hughes, and M. Day Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test Prog Neuropsychopharmacol Biol Psychiatry 32 2008 34 41
108. J.A. Milstein, J.W. Dalley, and T.W. Robbins Methylphenidate-induced impulsivity: Pharmacological antagonism by beta-adrenoreceptor blockade J Psychopharmacol 24 2010 309 321